LYNX1 CAPITAL MANAGEMENT LP

PrivateCIK: 1910456
InsiderLYNX1 CAPITAL MANAGEMENT LPCIK 1910456
IssuerTSCAN THERAPEUTICS, INC.CIK 1783328
10% Owner
Since May 2023
+7.50M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
7.50M acquired
Non-Derivative Transactions0
No non-derivative transactions reported
Derivative Transactions1

Pre-funded Warrant (right to buy)

Indirect
P · Purchase
Converts to

Common Stock

7.50M shares

Shares

+7.50M

Strike price

0.0001

Held after

7.50M

Exercisable

12/26/2024
LYNX1 CAPITAL MANAGEMENT LP — Insider Transaction (Form 4) Filed Dec 30, 2024 | Finecho